{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:03:45Z","timestamp":1760853825060,"version":"3.41.0"},"reference-count":50,"publisher":"Wiley","issue":"6-7","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":92,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Gene Med"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1002\/jgm.2829","type":"journal-article","created":{"date-parts":[[2015,4,28]],"date-time":"2015-04-28T02:27:52Z","timestamp":1430188072000},"page":"101-115","source":"Crossref","is-referenced-by-count":6,"title":["Adeno-associated virus mediated delivery of an engineered protein that combines the complement inhibitory properties of CD46, CD55 and CD59"],"prefix":"10.1002","volume":"17","author":[{"given":"Derek","family":"Leaderer","sequence":"first","affiliation":[{"name":"Department of Developmental, Molecular and Chemical Biology, Program in Genetics, Sackler School of Graduate Biomedical Sciences; Tufts University School of Medicine; Boston MA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siobhan M.","family":"Cashman","sequence":"additional","affiliation":[{"name":"Department of Developmental, Molecular and Chemical Biology, Program in Genetics, Sackler School of Graduate Biomedical Sciences; Tufts University School of Medicine; Boston MA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajendra","family":"Kumar-Singh","sequence":"additional","affiliation":[{"name":"Department of Developmental, Molecular and Chemical Biology, Program in Genetics, Sackler School of Graduate Biomedical Sciences; Tufts University School of Medicine; Boston MA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,7,24]]},"reference":[{"key":"10.1002\/jgm.2829-BIB0001|jgm2829-cit-0001","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/labinvest.2010.173","article-title":"Dynamic control of the complement system by modulated expression of regulatory proteins","volume":"91","author":"Thurman","year":"2011","journal-title":"Lab Invest"},{"key":"10.1002\/jgm.2829-BIB0002|jgm2829-cit-0002","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nri2620","article-title":"Complement regulators and inhibitory proteins","volume":"9","author":"Zipfel","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1002\/jgm.2829-BIB0003|jgm2829-cit-0003","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0031-6997(24)01349-8","article-title":"Therapeutic inhibition of the complement system","volume":"50","author":"Makrides","year":"1998","journal-title":"Pharmacol Rev"},{"key":"10.1002\/jgm.2829-BIB0004|jgm2829-cit-0004","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1600-065X.2008.00641.x","article-title":"The spectrum of complement alternative pathway-mediated diseases","volume":"223","author":"Holers","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1002\/jgm.2829-BIB0005|jgm2829-cit-0005","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s13238-012-2924-6","article-title":"Complement genetics, deficiencies, and disease associations","volume":"3","author":"Mayilyan","year":"2012","journal-title":"Protein Cell"},{"key":"10.1002\/jgm.2829-BIB0006|jgm2829-cit-0006","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","article-title":"Complement. First of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1002\/jgm.2829-BIB0007|jgm2829-cit-0007","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.exer.2011.06.015","article-title":"Elevated membrane attack complex in human choroid with high risk complement factor H genotypes","volume":"93","author":"Mullins","year":"2011","journal-title":"Exp Eye Res"},{"key":"10.1002\/jgm.2829-BIB0008|jgm2829-cit-0008","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1167\/iovs.11-8425","article-title":"C9-R95X polymorphism in patients with neovascular age-related macular degeneration","volume":"53","author":"Nishiguchi","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1002\/jgm.2829-BIB0009|jgm2829-cit-0009","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1590\/S0482-50042011000500009","article-title":"Expression of complement regulatory proteins CD55, CD59, CD35, and CD46 in rheumatoid arthritis","volume":"51","author":"Piccoli","year":"2011","journal-title":"Rev Bras Reumatol"},{"key":"10.1002\/jgm.2829-BIB0010|jgm2829-cit-0010","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.4049\/jimmunol.1203200","article-title":"Complement in immune and inflammatory disorders: therapeutic interventions","volume":"190","author":"Ricklin","year":"2013","journal-title":"J Immunol"},{"key":"10.1002\/jgm.2829-BIB0011|jgm2829-cit-0011","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00417-007-0660-z","article-title":"Twelve-month safety of intravitreal injections of bevacizumab (Avastin): results of the Pan-American Collaborative Retina Study Group (PACORES)","volume":"246","author":"Wu","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1002\/jgm.2829-BIB0012|jgm2829-cit-0012","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1600-0420.2007.01067.x","article-title":"Complications in patients after intravitreal injection of bevacizumab","volume":"86","author":"Shima","year":"2008","journal-title":"Acta Ophthalmol"},{"key":"10.1002\/jgm.2829-BIB0013|jgm2829-cit-0013","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/jgm.2698","article-title":"Gene therapy clinical trials worldwide to 2012 - an update","volume":"15","author":"Ginn","year":"2013","journal-title":"J Gene Med"},{"key":"10.1002\/jgm.2829-BIB0014|jgm2829-cit-0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019078","article-title":"A non membrane-targeted human soluble CD59 attenuates choroidal neovascularization in a model of age related macular degeneration","volume":"6","author":"Cashman","year":"2011","journal-title":"PLoS One"},{"key":"10.1002\/jgm.2829-BIB0015|jgm2829-cit-0015","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.it.2004.07.004","article-title":"CD46: expanding beyond complement regulation","volume":"25","author":"Riley-Vargas","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1002\/jgm.2829-BIB0016|jgm2829-cit-0016","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.4049\/jimmunol.149.9.2906","article-title":"Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor","volume":"149","author":"Coyne","year":"1992","journal-title":"J Immunol"},{"key":"10.1002\/jgm.2829-BIB0017|jgm2829-cit-0017","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.clim.2005.10.014","article-title":"Membrane complement regulatory proteins","volume":"118","author":"Kim","year":"2006","journal-title":"Clin Immunol"},{"key":"10.1002\/jgm.2829-BIB0018|jgm2829-cit-0018","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.1167\/iovs.08-2025","article-title":"Evaluation of adenovirus-delivered human CD59 as a potential therapy for AMD in a model of human membrane attack complex formation on murine RPE","volume":"49","author":"Ramo","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1002\/jgm.2829-BIB0019|jgm2829-cit-0019","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/gt.2011.6","article-title":"Adenovirus-mediated delivery of CD46 attenuates the alternative complement pathway on RPE: implications for age-related macular degeneration","volume":"18","author":"Sweigard","year":"2011","journal-title":"Gene Ther"},{"key":"10.1002\/jgm.2829-BIB0020|jgm2829-cit-0020","doi-asserted-by":"crossref","first-page":"6776","DOI":"10.1167\/iovs.10-5887","article-title":"Decay accelerating factor (CD55)-mediated attenuation of complement: therapeutic implications for age-related macular degeneration","volume":"51","author":"Ma","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1002\/jgm.2829-BIB0021|jgm2829-cit-0021","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1089\/hum.1996.7.2-215","article-title":"Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors","volume":"7","author":"Fallaux","year":"1996","journal-title":"Hum Gene Ther"},{"key":"10.1002\/jgm.2829-BIB0022|jgm2829-cit-0022","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1084\/jem.168.1.181","article-title":"Molecular cloning and chromosomal localization of human membrane cofactor protein (MCP). Evidence for inclusion in the multigene family of complement-regulatory proteins","volume":"168","author":"Lublin","year":"1988","journal-title":"J Exp Med"},{"key":"10.1002\/jgm.2829-BIB0023|jgm2829-cit-0023","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1089\/hum.2005.16.551","article-title":"Production of recombinant adeno-associated virus vectors","volume":"16","author":"Zolotukhin","year":"2005","journal-title":"Hum Gene Ther"},{"key":"10.1002\/jgm.2829-BIB0024|jgm2829-cit-0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/hgtb.2011.104","article-title":"Systemic errors in quantitative polymerase chain reaction titration of self-complementary adeno-associated viral vectors and improved alternative methods","volume":"23","author":"Fagone","year":"2012","journal-title":"Hum Gene Ther Methods"},{"key":"10.1002\/jgm.2829-BIB0025|jgm2829-cit-0025","doi-asserted-by":"crossref","first-page":"8092","DOI":"10.1074\/jbc.M111.291476","article-title":"PRELP protein inhibits the formation of the complement membrane attack complex","volume":"287","author":"Happonen","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1002\/jgm.2829-BIB0026|jgm2829-cit-0026","doi-asserted-by":"crossref","first-page":"7602","DOI":"10.1128\/JVI.00713-09","article-title":"The paramyxoviruses simian virus 5 and mumps virus recruit host cell CD46 to evade complement-mediated neutralization","volume":"83","author":"Johnson","year":"2009","journal-title":"J Virol"},{"key":"10.1002\/jgm.2829-BIB0027|jgm2829-cit-0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021621","article-title":"Soluble CD59 expressed from an adenovirus in vivo is a potent inhibitor of complement deposition on murine liver vascular endothelium","volume":"6","author":"Gandhi","year":"2011","journal-title":"PLoS One"},{"key":"10.1002\/jgm.2829-BIB0028|jgm2829-cit-0028","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.4049\/jimmunol.141.11.3923","article-title":"Biochemical characterization of membrane cofactor protein of the complement system","volume":"141","author":"Ballard","year":"1988","journal-title":"J Immunol"},{"key":"10.1002\/jgm.2829-BIB0029|jgm2829-cit-0029","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/00007890-199710270-00006","article-title":"Humoral injury in porcine livers perfused with human whole blood","volume":"64","author":"Satoh","year":"1997","journal-title":"Transplantation"},{"key":"10.1002\/jgm.2829-BIB0030|jgm2829-cit-0030","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.preteyeres.2009.11.003","article-title":"The pivotal role of the complement system in ageing and age-related macular degeneration: hypothesis re-visited","volume":"29","author":"Anderson","year":"2010","journal-title":"Prog Retin Eye Res"},{"key":"10.1002\/jgm.2829-BIB0031|jgm2829-cit-0031","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.molimm.2007.09.008","article-title":"Role of complement and complement regulators in the removal of apoptotic cells","volume":"45","author":"Trouw","year":"2008","journal-title":"Mol Immunol"},{"key":"10.1002\/jgm.2829-BIB0032|jgm2829-cit-0032","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/01.bor.0000172799.03379.86","article-title":"Complement and systemic lupus erythematosus","volume":"17","author":"Karp","year":"2005","journal-title":"Curr Opin Rheumatol"},{"key":"10.1002\/jgm.2829-BIB0033|jgm2829-cit-0033","first-page":"147","article-title":"Immunohistochemical determination of complement activation in joint tissues of patients with rheumatoid arthritis and osteoarthritis using neoantigen-specific monoclonal antibodies","volume":"37","author":"Kemp","year":"1992","journal-title":"J Clin Lab Immunol"},{"key":"10.1002\/jgm.2829-BIB0034|jgm2829-cit-0034","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1136\/ard.55.12.888","article-title":"Complement in acute and chronic arthritides: assessment of C3c, C9, and protectin (CD59) in synovial membrane","volume":"55","author":"Konttinen","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"10.1002\/jgm.2829-BIB0035|jgm2829-cit-0035","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1002\/art.20478","article-title":"Deletion of the gene encoding CD59a in mice increases disease severity in a murine model of rheumatoid arthritis","volume":"50","author":"Williams","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1002\/jgm.2829-BIB0036|jgm2829-cit-0036","doi-asserted-by":"crossref","first-page":"8955","DOI":"10.1073\/pnas.92.19.8955","article-title":"Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease","volume":"92","author":"Wang","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1002\/jgm.2829-BIB0037|jgm2829-cit-0037","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.molmed.2008.11.003","article-title":"Ocular gene therapy: current progress and future prospects","volume":"15","author":"Colella","year":"2009","journal-title":"Trends Mol Med"},{"key":"10.1002\/jgm.2829-BIB0038|jgm2829-cit-0038","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1182\/blood-2006-04-017913","article-title":"Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapy","volume":"108","author":"Jiang","year":"2006","journal-title":"Blood"},{"key":"10.1002\/jgm.2829-BIB0039|jgm2829-cit-0039","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1126\/science.1109557","article-title":"Complement factor H polymorphism in age-related macular degeneration","volume":"308","author":"Klein","year":"2005","journal-title":"Science"},{"key":"10.1002\/jgm.2829-BIB0040|jgm2829-cit-0040","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/path.4128","article-title":"Decreased membrane complement regulators in the retinal pigmented epithelium contributes to age-related macular degeneration","volume":"229","author":"Ebrahimi","year":"2013","journal-title":"J Pathol"},{"key":"10.1002\/jgm.2829-BIB0041|jgm2829-cit-0041","doi-asserted-by":"crossref","first-page":"483034","DOI":"10.1155\/2012\/483034","article-title":"Development of anti-VEGF therapies for intraocular use: a guide for clinicians","volume":"2012","author":"Keane","year":"2012","journal-title":"J Ophthalmol"},{"key":"10.1002\/jgm.2829-BIB0042|jgm2829-cit-0042","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.4049\/jimmunol.155.9.4135","article-title":"A novel bifunctional chimeric complement inhibitor that regulates C3 convertase and formation of the membrane attack complex","volume":"155","author":"Fodor","year":"1995","journal-title":"J Immunol"},{"key":"10.1002\/jgm.2829-BIB0043|jgm2829-cit-0043","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1097\/00007890-200006150-00011","article-title":"A recombinant soluble chimeric complement inhibitor composed of human CD46 and CD55 reduces acute cardiac tissue injury in models of pig-to-human heart transplantation","volume":"69","author":"Kroshus","year":"2000","journal-title":"Transplantation"},{"key":"10.1002\/jgm.2829-BIB0044|jgm2829-cit-0044","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/art.30222","article-title":"The benefit of targeted and selective inhibition of the alternative complement pathway for modulating autoimmunity and renal disease in MRL\/lpr mice","volume":"63","author":"Sekine","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1002\/jgm.2829-BIB0045|jgm2829-cit-0045","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1128\/JVI.01990-07","article-title":"Complement is an essential component of the immune response to adeno-associated virus vectors","volume":"82","author":"Zaiss","year":"2008","journal-title":"J Virol"},{"key":"10.1002\/jgm.2829-BIB0046|jgm2829-cit-0046","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/mt.2013.134","article-title":"AAV8 induces tolerance in murine muscle as a result of poor APC transduction, T cell exhaustion, and minimal MHCI upregulation on target cells","volume":"22","author":"Mays","year":"2014","journal-title":"Mol Ther"},{"key":"10.1002\/jgm.2829-BIB0047|jgm2829-cit-0047","doi-asserted-by":"crossref","first-page":"11854","DOI":"10.1073\/pnas.182412299","article-title":"Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy","volume":"99","author":"Gao","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1002\/jgm.2829-BIB0048|jgm2829-cit-0048","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1089\/hum.2009.031","article-title":"Effect of adeno-associated virus serotype and genomic structure on liver transduction and biodistribution in mice of both genders","volume":"20","author":"Paneda","year":"2009","journal-title":"Hum Gene Ther"},{"key":"10.1002\/jgm.2829-BIB0049|jgm2829-cit-0049","first-page":"333","article-title":"The complement system in liver diseases","volume":"3","author":"Qin","year":"2006","journal-title":"Cell Mol Immunol"},{"key":"10.1002\/jgm.2829-BIB0050|jgm2829-cit-0050","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1172\/JCI102008","article-title":"An estimation of the hepatic blood flow and splanchnic oxygen consumption in heart failure","volume":"27","author":"Myers","year":"1948","journal-title":"J Clin Invest"}],"container-title":["The Journal of Gene Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjgm.2829","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/jgm.2829\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T16:20:55Z","timestamp":1748362855000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jgm.2829"}},"subtitle":["SACT and DTAC inhibit activation of complement"],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":50,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2015,6]]}},"URL":"https:\/\/doi.org\/10.1002\/jgm.2829","relation":{},"ISSN":["1099-498X"],"issn-type":[{"type":"print","value":"1099-498X"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}